Therapeutic considerations in the use of intraperitoneal radiolabelled monoclonal antibodies in ovarian carcinoma.
Crowther, M E
Therapeutic considerations in the use of intraperitoneal radiolabelled monoclonal antibodies in ovarian carcinoma. [electronic resource] - Nuclear medicine communications Mar 1989 - 149-59 p. digital
Publication Type: Journal Article
0143-3636
10.1097/00006231-198903000-00004 doi
Adult
Aged
Antibodies, Monoclonal--adverse effects
Catheters, Indwelling--adverse effects
Female
Humans
Intestinal Diseases--etiology
Iodine Radioisotopes
Middle Aged
Neoplasm Staging
Ovarian Neoplasms--pathology
Peritoneal Neoplasms--pathology
Therapeutic considerations in the use of intraperitoneal radiolabelled monoclonal antibodies in ovarian carcinoma. [electronic resource] - Nuclear medicine communications Mar 1989 - 149-59 p. digital
Publication Type: Journal Article
0143-3636
10.1097/00006231-198903000-00004 doi
Adult
Aged
Antibodies, Monoclonal--adverse effects
Catheters, Indwelling--adverse effects
Female
Humans
Intestinal Diseases--etiology
Iodine Radioisotopes
Middle Aged
Neoplasm Staging
Ovarian Neoplasms--pathology
Peritoneal Neoplasms--pathology